Memphis Pharmaceuticals & Chemical Industries reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was EGP 551.26 million compared to EGP 518.11 million a year ago. Net income was EGP 74.09 million compared to EGP 41.81 million a year ago.